Blueprint Medicines Corporation (BPMC)

Blueprint Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	113.33	71.29	119.71	209.95	684.64	113.94
Short-Term Investments	534.58	639.36	825.28	267.17	187.21	369.62
Cash & Short-Term Investments	647.9	710.64	944.99	477.11	871.85	483.55
Cash Growth	-21.20%	-24.80%	98.06%	-45.28%	80.30%	-2.12%
Receivables	60.05	43.18	36.94	37.03	25.31	23.41
Inventory	30.94	21.22	29.7	21.82	8.58	-
Prepaid Expenses	37.71	33.35	35.02	18.06	22.02	9.32
Restricted Cash	-	-	-	-	-	0.5
Total Current Assets	776.6	808.39	1,047	554.03	927.76	516.79
Property, Plant & Equipment	113.17	115.65	115.2	120.86	101.67	111.11
Long-Term Investments	115.49	84.32	161.27	557.53	677.87	64.41
Other Long-Term Assets	33.21	40.89	26.78	19.81	11.09	15.39
Total Assets	1,038	1,049	1,350	1,252	1,718	707.69
Accounts Payable	4.93	4.71	2.73	8.33	4.37	4.79
Accrued Expenses	86.51	110.53	122.08	117.9	104.97	88.71
Current Portion of Long-Term Debt	74.91	69.48	34.14	-	-	-
Current Portion of Leases	12.24	11.93	10.58	8.09	7.94	6.82
Current Unearned Revenue	7.25	0.81	4.67	11.51	12.56	6.16
Other Current Liabilities	20.76	17.47	9.05	3.93	0.97	-
Total Current Liabilities	206.6	214.92	183.23	149.77	130.8	106.48
Long-Term Debt	432.3	610.96	535.28	-	-	-
Long-Term Leases	78.49	81.75	92.79	103.32	81.67	89.13
Long-Term Unearned Revenue	4.64	4.79	13.62	25.07	28.6	39.91
Other Long-Term Liabilities	5.77	6.21	10.3	3.34	7.24	7.81
Total Liabilities	727.79	918.64	835.23	281.49	248.31	243.34
Common Stock	0.06	0.06	0.06	0.06	0.06	0.05
Additional Paid-In Capital	2,565	2,474	2,358	2,250	2,107	1,412
Retained Earnings	-2,250.81	-2,339.94	-1,832.96	-1,275.44	-631.36	-945.24
Comprensive Income & Other	-3.85	-3.5	-10.44	-4.13	-5.21	-2.54
Total Common Equity	310.69	130.61	514.68	970.74	1,470	464.36
Shareholders' Equity	310.69	130.61	514.68	970.74	1,470	464.36
Total Liabilities & Equity	1,038	1,049	1,350	1,252	1,718	707.69
Total Debt	597.93	774.12	672.78	111.41	89.6	95.95
Net Cash (Debt)	137.67	-6.95	405.69	923.24	1,460	452.01
Net Cash Growth	-51.93%	-	-56.06%	-36.77%	223.03%	-8.50%
Net Cash Per Share	2.26	-0.11	6.80	15.78	26.00	9.45
Filing Date Shares Outstanding	62.62	61.23	59.98	59.2	57.96	54.03
Total Common Shares Outstanding	62.59	61.15	59.96	59.14	57.79	49.27
Working Capital	570	593.47	863.42	404.26	796.96	410.3
Book Value Per Share	4.96	2.14	8.58	16.41	25.44	9.42
Tangible Book Value	310.69	130.61	514.68	970.74	1,470	464.36
Tangible Book Value Per Share	4.96	2.14	8.58	16.41	25.44	9.42
Machinery	-	27.98	21.32	18.55	16.35	14.05
Construction In Progress	-	9.51	1.61	0.21	0.15	0.96
Leasehold Improvements	-	42.3	41.05	36.95	36.95	36.63

Source: S&P Capital IQ. Standard template.